CEFIZOX Drug Patent Profile
✉ Email this page to a colleague
When do Cefizox patents expire, and when can generic versions of Cefizox launch?
Cefizox is a drug marketed by Astellas and is included in three NDAs.
The generic ingredient in CEFIZOX is ceftizoxime sodium. There are five drug master file entries for this compound. Additional details are available on the ceftizoxime sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEFIZOX?
- What are the global sales for CEFIZOX?
- What is Average Wholesale Price for CEFIZOX?
Summary for CEFIZOX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 44 |
| Clinical Trials: | 1 |
| Patent Applications: | 5,154 |
| DailyMed Link: | CEFIZOX at DailyMed |
Recent Clinical Trials for CEFIZOX
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Khartoum | Phase 4 |
| Ministry of Health, Sudan | Phase 4 |
US Patents and Regulatory Information for CEFIZOX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astellas | CEFIZOX | ceftizoxime sodium | INJECTABLE;INJECTION | 063294-002 | Mar 31, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Astellas | CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER | ceftizoxime sodium | INJECTABLE;INJECTION | 050589-001 | Oct 3, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Astellas | CEFIZOX | ceftizoxime sodium | INJECTABLE;INJECTION | 050560-003 | Sep 15, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
